ARTICLE
|
doi:10.20944/preprints202405.0962.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Rasburicase; Tumor Lysis syndrome; Cost-effectiveness; 3 mg single fixed dose
Online: 14 May 2024 (12:46:34 CEST)